Furthermore, HIPe and CHIP can be exploited for further development into drugs to treat histone- and/or NETs-mediated diseases such as sepsis, atherosclerosis, acute lung injury, ARDS, and inflammatory diseases. Here, STUB1 is linked to atherosclerosis.